Pan-European registry study shows benefits of cancer genome sequencing for children with cancer

n some cases, cancer genome analysis can help find a suitable therapy for children with relapsed cancer and delay the progression of the disease.
These are the findings of the INFORM registry study conducted by the Hopp Children´s Cancer Center Heidelberg (KiTZ), which systematically investigated the benefits of molecular precision oncology in children. The results of the pan-European project are being presented at the conference of the American Society of Clinical Oncology (ASCO), which ...